نتایج جستجو برای: booster vaccination

تعداد نتایج: 64006  

Journal: :archives of clinical infectious diseases 0
iraj sedighi department of pediatrics, hamadan university of medical sciences, hamadan, ir iran hamid rahimi department of infectious diseases, infectious diseases and tropical medicine research center, isfahan university of medical sciences, isfahan, ir iran monir sadat emadoleslami department of pediatrics, isfahan university of medical sciences, isfahan, ir iran alireza fahimzad department of pediatrics, pediatric infectious research center, shahid beheshti university of medical sciences, tehran, ir iran firuzeh hosseini department of pediatrics, hamadan university of medical sciences, hamadan, ir iran mandana afsharian department of pediatrics, nosocomial infections research center, kermanshah university of medical sciences, kermanshah, ir iran

background pertussis is a highly communicable, vaccine-preventable respiratory disease; which may circulate even in populations with high vaccination coverage. although frequent, but it is often underestimated as a cause of prolonged cough illness in both children and adults. without boosting, the protection of the childhood vaccination would be minimal after 10 years. the need for adult booste...

Journal: :hepatitis monthly 0
kamran bagheri lankarani health policy research center, shiraz university of medical sciences, ir iran +98-7112309615, [email protected]; health policy research center, shiraz university of medical sciences, ir iran +98-7112309615, [email protected]

2004
M. A. Islam S. Akter

The duck plague vaccine (DPV) is locally produced from the Livestock Research Institute (LRI), Mohakhali, Dhaka which is used to control the duck plague viral disease in ducks in Bangladesh. Efficacy of this vaccine reports has no, so to say on ducks in Bangladesh. Three weeks old 50 Khaki Cambell Ducks were used to evaluate the induced of immune responses of duck plague vaccine during the peri...

2018
Hong Zhao Yi-Hua Zhou

The significance of vaccination against hepatitis B during infancy is recognized worldwide, however, whether booster or revaccination after a period of time following the primary vaccination is required remains controversial. Recently, cross-sectional epidemiological surveys found that HBsAg prevalence in subjects born after the implementation of mass vaccination was increased with age, which w...

2014
Olumuyiwa O Odusanya Yetunde A Kuyinu Omolara A Kehinde Fakrudeen Shafi Nancy François Juan Pablo Yarzabal Kurt Dobbelaere Jens U Rüggeberg Dorota Borys Lode Schuerman

In a previous study, 3-dose primary vaccination of Nigerian infants with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) was immunogenic for vaccine pneumococcal serotypes, with comparable tolerability between PHiD-CV and control groups. In an open-label study (ClinicalTrials.gov, NCT01153893), 68 primed children received a PHiD-CV booster dos...

2014
Jared B. Ditkowsky Kevin Schwartzman

Novel tuberculosis vaccines are in varying stages of pre-clinical and clinical development. This study seeks to estimate the potential cost-effectiveness of a BCG booster vaccine, while accounting for costs of large-scale clinical trials, using the MVA85A vaccine as a case study for estimating potential costs. We conducted a decision analysis from the societal perspective, using a 10-year time ...

خلیلیان, علیرضا, شجاعی, جلیل, صفار, محمد جعفر, صفار, هیوا, عجمی, ابوالقاسم, مسلمی زاده, نرگس,

Background and purpose: After marked reduction of pertussis during recent two decades the incidence of disease is increasing, particularly in early infancy. The main sources of infection in this age group are mother and other household close contacts. Our purpose was to examine whether administrating prepregnancy pertussis booster dose can induce long-term protection enough to provide higher ma...

Journal: :PLoS ONE 2009
Angelika Banzhoff Roberto Gasparini Franco Laghi-Pasini Tommaso Staniscia Paolo Durando Emanuele Montomoli Pamela Capecchi Pamela di Giovanni Laura Sticchi Chiara Gentile Anke Hilbert Volker Brauer Sandrine Tilman Audino Podda

BACKGROUND Pathogenic avian influenza virus (H5N1) has the potential to cause a major global pandemic in humans. Safe and effective vaccines that induce immunologic memory and broad heterotypic response are needed. METHODS AND FINDINGS Healthy adults aged 18-60 and > 60 years (n = 313 and n = 173, respectively) were randomized (1:1) to receive two primary and one booster injection of 7.5 micr...

2014
Susanne P. Stoof Fiona R. M. van der Klis Debbie M. van Rooijen Mirjam J. Knol Elisabeth A. M. Sanders Guy A. M. Berbers

BACKGROUND Meningococcal serogroup C (MenC) specific antibody levels decline rapidly after a single primary MenC conjugate (MenCC) vaccination in preschool children. A second MenCC vaccination during (pre)adolescence might attain longer lasting individual and herd protection. We aimed to establish an appropriate age for a (pre)adolescent MenCC booster vaccination. METHODS A phase-IV trial wit...

Journal: :Clinical and vaccine immunology : CVI 2014
Olajumoke O Fadugba Li Wang Qingxia Chen Natasha B Halasa

Given the resurgence of pertussis despite high rates of vaccination with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine, a better understanding of vaccine-induced immune responses to Bordetella pertussis is needed. We investigated the antibody, cell-mediated, and cytokine responses to B. pertussis antigens in children who received the primary vaccination series (at 2, 4, and 6 months...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید